Multidrug-resistant tuberculous meningitis in an HIV-positive patient: A challenging disease

AIDS Patient Care and STDs

Volumn 21, Issue 3, 2007, Pages 149-153

  Meybeck, Agnès ^a   Calbet, J ^a   Ruimy, R ^a   Mashri, K ^a   Jachym, M ^b   Joly, V ^a   Yeni, P ^a  

^a BICHAT HOSPITAL   (France)

^b Centre Hospitalier de Bligny   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ANTIRETROVIRUS AGENT; CAPREOMYCIN; CD4 ANTIGEN; CEFTRIAXONE; COTRIMOXAZOLE; CYCLOSERINE; EFAVIRENZ; ENFUVIRTIDE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MOXIFLOXACIN; PREDNISONE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; THIONAMIDE; TUBERCULOSTATIC AGENT; VIRUS RNA; ZIDOVUDINE;

ADD ON THERAPY; ADULT; ARTICLE; BLOOD TOXICITY; CAMEROON; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FEMALE; GHANA; HEARING LOSS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIGRATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; OPTIC NEURITIS; SUPERINFECTION; TREATMENT RESPONSE; TUBERCULOUS MENINGITIS;

ADULT; ANTITUBERCULAR AGENTS; CAMEROON; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EMIGRATION AND IMMIGRATION; FEMALE; FRANCE; GHANA; HIV SEROPOSITIVITY; HUMANS; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 34247197024     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.0058     Document Type: Article

References (20)

1. Khawcharoenporn T, Apisarnthanarak A, Sakonlaya D, Mundy LM, Bailey TC. Dual infection with Mycobacterium tuberculosis and Pneumocystis jiroveci lymphadenitis in a patient with HIV infection: Case report and review of the literature. AIDS Patient Care STDs 2006;20:1-5.
2. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992;326:668-672.
3. Nachega JB, Chaisson RE. Tuberculosis drug resis-tance: A global threat. Clin Infect Dis 2003;3:S24-S30.
4. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002;185:1197-1202.
5. Centers for Disease Control. Nosocomial transmission of multi-drug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991;40:585-591.
6. Salomon N, Perlman DC, Friedmann P, Buchstein S, Kreiswirth BN, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis 1995;21:1245-1252.
7. Patel VB, Padayatchi N, Bhigjee AI, et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 2004;38:851-856.
8. Chan ED, Laurel V, Strand MJ, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 169:1103-1109.
9. Drobniewski FA, Wilson SM. The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a molecular story. J Med Microbiol 1998; 47:189-196.
10. Srivastava K, Das R, Jakhmola P, et al. Correlation of mutations detected by INNO-LIPA with levels of rifampicin resistance in Mycobacterium tuberculosis. Indian J Med Res 2004;120:100-105.
11. Di Perri G, Bonora S. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? J Antimicrob Chemother 2004;54:593-602.
12. Gosling RD, Uiso LO, Sam NE, et al. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 2003;168: 1342-1345.
13. Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis 2003;3:432-442.
14. Bastian I, Colebrunders R. Treatment and prevention of multidrug-resistant tuberculosis. Drugs 1999;58: 633-661
15. Ellard GA, Humphries MJ, Allen BW. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis 1993;148:650-655.
16. Berning SE, Cherry TA, Iseman MD. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: Case report. Clin Infect Dis 2001;32: 643-646.
17. Vajpayee M, Kanswal S, Seth P, Wig N, Pandey RM. Tuberculosis infection in HIV-infected Indian patients. AIDS Patient Care STDs 2004;18:209-213.
18. Dean GL, Edwards SG, Ives NJ, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002;16:75-83.
19. Martin DJ, Sim JG, Sole GJ, et al. CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retroviral 1995;8:386-391.
20. Dheda K, Lampe FC, Johnson MA, Lipman MC. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004; 190:1670-1676.